WallStreetZenWallStreetZen

NASDAQ: LXEO
Lexeo Therapeutics Inc Stock Ownership - Who owns Lexeo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lexeo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jose Manuel OteroCOO2026-09-142,110$2.64
$5.58kBuy
Narinder Pal BhallaMed2026-09-142,714$3.58
$9.71kBuy
Richard Nolan TownsendCEO2026-09-142,306$2.64
$6.10kBuy
Jose Manuel OteroCOO2026-08-181,304$4.96
$6.46kSell
Richard Nolan TownsendCEO2026-08-183,345$4.95
$16.56kSell
Louis Edward TamayoCFO2026-08-184,117$4.91
$20.20kSell
Louis Edward TamayoChief Financial Officer2026-07-014,641$4.49
$20.84kSell
Richard Nolan TownsendChief Executive Officer2026-07-0125,947$4.48
$116.24kSell
Jose Manuel OteroChief Operating Officer2026-07-014,666$4.48
$20.90kSell
Narinder Pal BhallaChief Medical Officer2026-07-0122,306$4.42
$98.59kSell

1 of 3

LXEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LXEO insiders and whales buy or sell their stock.

LXEO Shareholders

What type of owners hold Lexeo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Longitude Capital Partners IV LLC3.13%2,567,100$7.86MInsider
Omega Fund VI LP2.63%2,157,623$6.60MInsider
Invest A. Lundbeckfond2.24%1,835,959$5.62MInsider
Richard Nolan Townsend0.46%376,778$1.15MInsider
Jose Manuel Otero0.17%138,288$423.16kInsider
Louis Edward Tamayo0.11%92,907$284.30kInsider
Narinder Pal Bhalla0.10%84,908$259.82kInsider
Eric Adler0.09%72,646$222.30kInsider
Jenny Robertson0.08%68,381$209.25kInsider
Tai Sandi See0.08%65,476$200.36kInsider

1 of 3

LXEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LXEO0.11%9.20%Net SellingNet Selling
BCYC0.05%43.35%Net SellingNet Selling
CYPH0.01%99.99%Net BuyingNet Buying
CUVL0.00%0.00%
LCTX0.05%60.39%Net Selling
View Top Biotech Stocks

Lexeo Therapeutics Stock Ownership FAQ

Who owns Lexeo Therapeutics?

Lexeo Therapeutics (NASDAQ: LXEO) is owned by 0.11% institutional shareholders, 9.20% Lexeo Therapeutics insiders, and 90.69% retail investors. Longitude Capital Partners IV LLC is the largest individual Lexeo Therapeutics shareholder, owning 2.57M shares representing 3.13% of the company. Longitude Capital Partners IV LLC's Lexeo Therapeutics shares are currently valued at $7.86M.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.